136 related articles for article (PubMed ID: 4679251)
1. [Pharmacological interference of glibornuride with sulfaphenazole, phenylbutazone, and phenprocoumon in man].
Eckhardt W; Rudolph R; Sauer H; Schubert WR; Undeutsch D
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2212. PubMed ID: 4679251
[No Abstract] [Full Text] [Related]
2. [Pharmacokinetics of glibornuride].
Rentsch G; Schmidt HA; Rieder J
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2209. PubMed ID: 4679250
[No Abstract] [Full Text] [Related]
3. [Thyroid gland function of patients with diabetes in long-term use of glibornuride].
Reinwein D
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2221. PubMed ID: 4125093
[No Abstract] [Full Text] [Related]
4. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
Beyer J; Gather W; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
[No Abstract] [Full Text] [Related]
5. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
Beyer J; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
[No Abstract] [Full Text] [Related]
6. [Effect of the oral antidiabetic agent glibornuride on blood coagulation, blood platelets, and fibrinolysis].
Voss D; Fuchs G; Schneider D; Schneider J
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2219. PubMed ID: 4679252
[No Abstract] [Full Text] [Related]
7. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
Beyer J; Cordes U; Krall H; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
[No Abstract] [Full Text] [Related]
8. [Clinical experiences in long-term therapy of adult diabetes using glibornuride (Ro 6-4563)].
Ewald W; Hartmann HM; Haupt E; Kunkel W; Neubauer M; Bartelt KM; Beyer J; Cordes U; Schulz F; Schöffling K
Med Klin; 1973 Mar; 68(12):376-85. PubMed ID: 4806346
[No Abstract] [Full Text] [Related]
9. [Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin].
Beyer J; Cordes U; Sell G; Krall H; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2172. PubMed ID: 4679247
[No Abstract] [Full Text] [Related]
10. Proceedings: Half-life of phenprocoumarol (Marcumar R) during treatment with insulin and sulfonylureas in diabetics.
Heine P; Kewitz H; Wiegboldt KA
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R30. PubMed ID: 4276557
[No Abstract] [Full Text] [Related]
11. [Extrapancreatic effects of sulfonylurea compounds. V. Studies on the antilipolytic effect of glibornuride].
Rosak C; Bartelt KM; Haupt E; Beyer J; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2181. PubMed ID: 4146791
[No Abstract] [Full Text] [Related]
12. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
Lorch E; Gey KF; Sommer P
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964
[No Abstract] [Full Text] [Related]
13. [Metabolism of glibornuride in the human].
Bigler F; Quitt P; Vecchi M; Vetter W
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2191. PubMed ID: 4679249
[No Abstract] [Full Text] [Related]
14. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
Pond SM; Birkett DJ; Wade DN
Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
[TBL] [Abstract][Full Text] [Related]
15. A clinical trial of glibornuride in maturity-onset diabetes mellitus.
Tandhanand S; Vannasaeng S; Aswapokee N; Soongsavang V; Aphonsuvan S
J Med Assoc Thai; 1974 May; 57(5):232-6. PubMed ID: 4832761
[No Abstract] [Full Text] [Related]
16. [Results of a clinical test on the oral antidiabetic agent glibornuride (Ro 6-4563)].
Leubner H
Wien Med Wochenschr; 1973 Apr; 123(17):277-82. PubMed ID: 4574026
[No Abstract] [Full Text] [Related]
17. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.
Iacono G; Ghionni A; Colucci M; Verde G; Caputo G
Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166
[No Abstract] [Full Text] [Related]
18. A study of the possible interaction of indoprofen with hypoglycemic sulfonylureas in diabetic patients.
Pedrazzi F; Bommartini F; Freddo J; Emanueli A
Eur J Rheumatol Inflamm; 1981; 4(1):26-31. PubMed ID: 7042358
[TBL] [Abstract][Full Text] [Related]
19. [Glydiazinamide-induced changes in the oral glucose tolerance of 15 adult diabetics].
Vailati G; Montini M; Pagani G; Caputo G
Minerva Med; 1972 Oct; 63(69):3752-7. PubMed ID: 5078667
[No Abstract] [Full Text] [Related]
20. [Studies on the mechanism of action of sulfonylurea compounds. Effect of glibornuride and insulin on blood sugar, plasma catecholamines and on the immunologically determinable insulin following blockade of adrenergic receptors].
Cordes U; Beyer J; Sell G; Haupt E; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2164. PubMed ID: 4146790
[No Abstract] [Full Text] [Related]
[Next] [New Search]
